Anaplastic thyroid carcinoma: an overview.

Cornett, Wendy R; Sharma, Anand K; Day, Terry A; Richardson, Mary S; Hoda, Rana S; van Heerden, Jon A; Fernandes, Jyotika K

Cornett, Wendy R; Sharma, Anand K; Day, Terry A; Richardson, Mary S; Hoda, Rana S; van Heerden, Jon A; Fernandes, Jyotika K.

Afiliación

Cornett WR; The Medical University of South Carolina, Clinical Sciences Building, Charleston, SC 29425, USA. cornettw@musc.edu

Curr Oncol Rep ; 9(2): 152-8, 2007 Mar.

Article en En | MEDLINE | ID: mdl-17288883

RESUMEN

Thyroid cancer is an uncommon malignancy that accounts for roughly 1% of all new cancers. Although anaplastic lesions constitute fewer than 5% of thyroid cancers, they represent over half of thyroid cancer-related deaths. The relative rarity of anaplastic thyroid cancer, its aggressive nature, and its rapidly fatal course have contributed to the difficulty in developing effective treatment for this disease. Radiation, chemotherapy, and surgery are rarely curative, but combinations of these modalities appear to offer greater benefit than any single treatment. New treatment modalities are desperately required, and promising molecular-based therapies are being investigated.

Asunto(s)

Carcinoma/patología; Neoplasias de la Tiroides/patología; Carcinoma/terapia; Humanos; Neoplasias de la Tiroides/terapia

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma Límite: Humans Idioma: En Revista: Curr Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links